AI-driven Structure-enabled Antiviral Platform (ASAP) — John Damon Chodera (SLOAN-KETTERING INST CAN RESEARCH)
PROJECT SUMMARY/ABSTRACT - Overall SARS-CoV-2 continues to cause severe morbidity and mortality in the ongoing pandemic. Future RNA virus epidemics and pandemics are inevitable. New clinical-trial-rea
| Project title | AI-driven Structure-enabled Antiviral Platform (ASAP) |
|---|---|
| Project number | 1U19AI171399-01 |
| PI name | John Damon Chodera |
| Institution | SLOAN-KETTERING INST CAN RESEARCH |
| Funding mechanism | U19 |
| Agency | NIAID |
| Award amount | $67.67M |
| Fiscal year | 2022 |
| Project start | 2022-05-16T00:00:00 |
| Project end | 2025-04-30T00:00:00 |
| Abstract | PROJECT SUMMARY/ABSTRACT - Overall SARS-CoV-2 continues to cause severe morbidity and mortality in the ongoing pandemic. Future RNA virus epidemics and pandemics are inevitable. New clinical-trial-rea |
| Key terms | <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Antiviral Agents><Antiviral Drugs><Anti |
$799/mo
Try GrantRadar →